对于阿尔茨海默病的表征和预测,纵向痴呆的轨迹
Antoine de Mori1, Clovis Tauber1, 1
1Université de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, 37032, Tours, France.
Computers in biology and medicine
|May 9, 2025
概括
这项研究引入了一种新的模型,用于使用多式联络数据预测阿尔茨海默病 (AD) 的进展. 该模型准确预测个体痴呆的发展轨迹和诊断转换,有助于对神经退行性疾病的早期干预.
科学领域:
- 神经科学是一个神经科学.
- 医疗成像医学成像
- 生物统计学 生物统计学
背景情况:
- 阿尔茨海默氏症 (AD) 是一个主要的全球性神经退行性挑战,影响着数百万.
- 早期识别AD风险对于及时干预和疾病管理至关重要.
- 预测个体的AD进展和动态演变仍然是一个重要的研究障碍.
研究的目的:
- 开发和验证一种用于捕捉和预测人口层面和个体痴呆症轨迹的模型.
- 定义和建模静态痴呆评分 (SDS) 以评估当前痴呆状态及其时间演变.
- 为了能够在较长时间内对患者进行痴呆症进展的具体预测.
主要方法:
- 利用多模式临床数据,包括MP-RAGEMRI扫描,认知评估和人口统计数据.
- 采用贝叶斯的非线性混合效应方法来建模静态痴呆评分 (SDS) 的时间演变.
- 生成了人口级别的痴呆症进展曲线和患者特定的轨迹模型.
主要成果:
- 该模型的人口水平曲线准确地反映了已确定的阿尔茨海默病进展趋势.
- 个体特定的参数有效地描述了个性化的疾病进展.
- 在诊断 (0.952±0.013) 和AD转换 (0.916±0.022) 中提前三年实现了高预测准确度.
结论:
- 开发的方法显示了阿尔茨海默病分类和进展预测的巨大潜力.
- 该模型有助于临床医生和研究人员早期检测非典型疾病轨迹.
- 增强临床决策和治疗规划,为患者进行纵向随访.
相关概念视频
Alzheimer's Disease: Overview
323
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
323
Dementia
70
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
70
Alzheimer's Disease: Treatment
128
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128
Long-term Depression
2.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.4K
Cognitive Development During Adulthood
28
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
28


